Exact Mass: 324.0304

Exact Mass Matches: 324.0304

Found 65 metabolites which its exact mass value is equals to given mass value 324.0304, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Uridine 5'-monophosphate

{[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C9H13N2O9P (324.0359)


Uridine 5-monophosphate (UMP), also known as uridylic acid or uridylate, belongs to the class of organic compounds known as pyrimidine ribonucleoside monophosphates. These are pyrimidine ribobucleotides with monophosphate group linked to the ribose moiety. UMP consists of a phosphate group, a pentose sugar ribose, and the nucleobase uracil; hence, it is a ribonucleotide monophosphate. Uridine 5-monophosphate exists in all living species, ranging from bacteria to plants to humans. UMP is a nucleotide that is primarily used as a monomer in RNA biosynthesis. Uridine monophosphate is formed from Orotidine 5-monophosphate (orotidylic acid) in a decarboxylation reaction catalyzed by the enzyme orotidylate decarboxylase. Within humans, uridine 5-monophosphate participates in a number of enzymatic reactions. In particular, uridine 5-monophosphate can be converted into uridine 5-diphosphate through the action of the enzyme UMP-CMP kinase. In addition, uridine 5-monophosphate can be biosynthesized from uridine 5-diphosphate through its interaction with the enzyme soluble calcium-activated nucleotidase 1. In brain research studies, uridine monophosphate has been used as a convenient delivery compound for uridine. Uridine is present in many foods, mainly in the form of RNA. Non-phosphorylated uridine is not bioavailable beyond first-pass metabolism. In a study, gerbils fed a combination of uridine monophosphate, choline, and docosahexaenoic acid (DHA) were found to have significantly improved performance in running mazes over those not fed the supplements, implying an increase in cognitive function (PMID: 18606862). 5′-UMP. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=58-97-9 (retrieved 2024-07-02) (CAS RN: 58-97-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Uridine 5'-monophosphate (5'-?Uridylic acid), a monophosphate form of UTP, can be acquired either from a de novo pathway or degradation products of nucleotides and nucleic acids in vivo and is a major nucleotide analogue in mammalian milk[1]. Uridine 5'-monophosphate (5'-?Uridylic acid), a monophosphate form of UTP, can be acquired either from a de novo pathway or degradation products of nucleotides and nucleic acids in vivo and is a major nucleotide analogue in mammalian milk[1]. Uridine 5'-monophosphate (5'-?Uridylic acid), a monophosphate form of UTP, can be acquired either from a de novo pathway or degradation products of nucleotides and nucleic acids in vivo and is a major nucleotide analogue in mammalian milk[1].

   

Pseudouridine 5'-phosphate

{[(2R,3S,4R,5S)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C9H13N2O9P (324.0359)


Pseudouridine (5-ribosyluracil) is a ubiquitous yet enigmatic constituent of structural RNAs (transfer, ribosomal, small nuclear, and small nucleolar). Although pseudouridine (psi) was the first modified nucleoside to be discovered in RNA, and is the most abundant, its biosynthesis and biological roles have remained poorly understood since its identification as a "fifth nucleoside" in RNA. Recently, a combination of biochemical, biophysical, and genetic approaches has helped to illuminate the structural consequences of psi in polyribonucleotides, the biochemical mechanism of U-->psi isomerization in RNA, and the role of modification enzymes (psi synthases) and box H/ACA snoRNAs, a class of eukaryotic small nucleolar RNAs, in the site-specific biosynthesis of psi. Through its unique ability to coordinate a structural water molecule via its free N1-H, psi exerts a subtle but significant "rigidifying" influence on the nearby sugar-phosphate backbone and also enhances base stacking. These effects may underlie the biological role of most (but perhaps not all) of the psi residues in RNA. Certain genetic mutants lacking specific psi residues in tRNA or rRNA exhibit difficulties in translation, display slow growth rates, and fail to compete effectively with wild-type strains in mixed culture. In particular, normal growth is severely compromised in an Escherichia coli mutant deficient in a pseudouridine synthase responsible for the formation of three closely spaced psi residues in the mRNA decoding region of the 23S rRNA. Such studies demonstrate that pseudouridylation of RNA confers an important selective advantage in a natural biological context. PMID: 10902565 [HMDB]. Pseudouridine 5-phosphate is found in many foods, some of which are garland chrysanthemum, chives, broad bean, and green bell pepper. Pseudouridine (5-ribosyluracil) is a ubiquitous yet enigmatic constituent of structural RNAs (transfer, ribosomal, small nuclear, and small nucleolar). Although pseudouridine (psi) was the first modified nucleoside to be discovered in RNA, and is the most abundant, its biosynthesis and biological roles have remained poorly understood since its identification as a "fifth nucleoside" in RNA. Recently, a combination of biochemical, biophysical, and genetic approaches has helped to illuminate the structural consequences of psi in polyribonucleotides, the biochemical mechanism of U-->psi isomerization in RNA, and the role of modification enzymes (psi synthases) and box H/ACA snoRNAs, a class of eukaryotic small nucleolar RNAs, in the site-specific biosynthesis of psi. Through its unique ability to coordinate a structural water molecule via its free N1-H, psi exerts a subtle but significant "rigidifying" influence on the nearby sugar-phosphate backbone and also enhances base stacking. These effects may underlie the biological role of most (but perhaps not all) of the psi residues in RNA. Certain genetic mutants lacking specific psi residues in tRNA or rRNA exhibit difficulties in translation, display slow growth rates, and fail to compete effectively with wild-type strains in mixed culture. In particular, normal growth is severely compromised in an Escherichia coli mutant deficient in a pseudouridine synthase responsible for the formation of three closely spaced psi residues in the mRNA decoding region of the 23S rRNA. Such studies demonstrate that pseudouridylation of RNA confers an important selective advantage in a natural biological context. PMID: 10902565.

   

5-O-(1-Carboxyvinyl)-3-phosphoshikimate

5-(1-carboxyethenoxy)-4-hydroxy-3-phosphonooxycyclohexene-1-carboxylic acid

C10H13O10P (324.0246)


   

Uridine 3'-monophosphate

{[(2R,3S,4R,5R)-4-hydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid

C9H13N2O9P (324.0359)


Uridine 3-monophosphate (3-UMP) belongs to the class of compounds called pentose phosphates. These are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups. Uridine 3-monophosphate has been identified in the human placenta (PMID: 32033212). COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Uridine 2'-phosphate

{[(2R,3R,4R,5R)-2-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid

C9H13N2O9P (324.0359)


Uridine 2- phosphate is a product of the decylclization reaction carried out by the enzyme 2,3-cyclic nucleotide-3-phosphodiesterase (CNPase, EC 3.1.4.37) which hydrolyses Uridine 2,3-cyclic phosphate to Uridine 2-phosphate. CNPase is a unique RNase in that it only cleaves nucleoside 2,3-cyclic phosphates and not the RNA internucleotide linkage, like other RNases such as RNase A and RNase T1. [HMDB] Uridine 2- phosphate is a product of the decylclization reaction carried out by the enzyme 2,3-cyclic nucleotide-3-phosphodiesterase (CNPase, EC 3.1.4.37) which hydrolyses Uridine 2,3-cyclic phosphate to Uridine 2-phosphate. CNPase is a unique RNase in that it only cleaves nucleoside 2,3-cyclic phosphates and not the RNA internucleotide linkage, like other RNases such as RNase A and RNase T1.

   

Dorzolamide

(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulphonic acid amide

C10H16N2O4S3 (324.0272)


Dorzolamide is only found in individuals that have used or taken this drug. It is a carbonic anhydrase (CA) inhibitor. It is used in ophthalmic solutions (Trusopt) to lower intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension.Dorzolamide is a sulfonamide and a highly specific carbonic anhydrase II (CA-II) inhibitor, which is the main CA isoenzyme involved in aqueous humor secretion. Inhibition of CA-II in the ciliary processes of the eye decreases aqueous humor secretion, presumably by slowing the formation of bicarbonate ions with subsequent reduction in sodium and fluid transport. Dorzolamide also accumulates in red blood cells as a result of CA-II binding, as CA-II is found predominantly in erythrocytes. However, sufficient CA-II activity remains so that adverse effects due to systemic CA inhibition are not observed. S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EC - Carbonic anhydrase inhibitors D004791 - Enzyme Inhibitors > D002257 - Carbonic Anhydrase Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor

   

Ethyl-4,4-dichlorobenzilate

Ethyl 2-hydroxy-2,2-bis(4-chlorophenyl)acetate

C16H14Cl2O3 (324.032)


   

6-Chlorocatechin

6-chloro-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, 9ci

C15H13ClO6 (324.0401)


6-Chlorocatechin is a constituent of the roots of Rumex patientia (patience dock). Constituent of the roots of Rumex patientia (patience dock)

   

1-(4-Chlorophenyl)-3-((4-methylphenyl)sulfonyl)urea

N-(4-Chlorophenyl)-n-(4-methylbenzenesulphonyl)carbamimidic acid

C14H13ClN2O3S (324.0335)


   

[(2S,3R,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

{[5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C9H13N2O9P (324.0359)


   

Dulofibrate

4-Chlorophenyl 2-(4-chlorophenoxy)-2-methylpropanoic acid

C16H14Cl2O3 (324.032)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

   

(-)-6-Chloroepicatechin

(-)-6-Chloroepicatechin

C15H13ClO6 (324.0401)


   
   

(3R)-6-hydroxy-3-hydroxymethyl-2-methyl-2,3-dihydro-10H-3r,10ac-epidisulfano-pyrazino[1,2-a]indole-1,4-dione|Dehydrogliotoxin|Dehydroglyotoxin

(3R)-6-hydroxy-3-hydroxymethyl-2-methyl-2,3-dihydro-10H-3r,10ac-epidisulfano-pyrazino[1,2-a]indole-1,4-dione|Dehydrogliotoxin|Dehydroglyotoxin

C13H12N2O4S2 (324.0238)


   
   

Uridine 5-monophosphate

Uridine 5-monophosphate

C9H13N2O9P (324.0359)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.085

   

Uridine monophosphate

Uridine 5_-monophosphate

C9H13N2O9P (324.0359)


A pyrimidine ribonucleoside 5-monophosphate having uracil as the nucleobase. COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Uridine 5'-monophosphate (5'-?Uridylic acid), a monophosphate form of UTP, can be acquired either from a de novo pathway or degradation products of nucleotides and nucleic acids in vivo and is a major nucleotide analogue in mammalian milk[1]. Uridine 5'-monophosphate (5'-?Uridylic acid), a monophosphate form of UTP, can be acquired either from a de novo pathway or degradation products of nucleotides and nucleic acids in vivo and is a major nucleotide analogue in mammalian milk[1]. Uridine 5'-monophosphate (5'-?Uridylic acid), a monophosphate form of UTP, can be acquired either from a de novo pathway or degradation products of nucleotides and nucleic acids in vivo and is a major nucleotide analogue in mammalian milk[1].

   

URIDINE-5-MONOPHOSPHATE

URIDINE-5-MONOPHOSPHATE

C9H13N2O9P (324.0359)


   

UMP; LC-tDDA; CE10

UMP; LC-tDDA; CE10

C9H13N2O9P (324.0359)


   

UMP; LC-tDDA; CE20

UMP; LC-tDDA; CE20

C9H13N2O9P (324.0359)


   

UMP; LC-tDDA; CE30

UMP; LC-tDDA; CE30

C9H13N2O9P (324.0359)


   

UMP; LC-tDDA; CE40

UMP; LC-tDDA; CE40

C9H13N2O9P (324.0359)


   

Arabinoside uridinemonophosphate

Arabinoside uridinemonophosphate

C9H13N2O9P (324.0359)


   

Arabinose Uridinemonophosphate

Arabinose Uridinemonophosphate

C9H13N2O9P (324.0359)


   

6-Chlorocatechin

6-chloro-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, 9ci

C15H13ClO6 (324.0401)


   

4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]benzaldehyde

4-[2-(2,6-dichloro-4-methylphenoxy)ethoxy]benzaldehyde

C16H14Cl2O3 (324.032)


   

4-(2,6-DICHLORO-BENZYLOXY)-3-ETHOXY-BENZALDEHYDE

4-(2,6-DICHLORO-BENZYLOXY)-3-ETHOXY-BENZALDEHYDE

C16H14Cl2O3 (324.032)


   

(R)-[3,4-(METHYLENEDIOXY)PHENYL]-1-BUTYLAMINEHYDROCHLORIDE

(R)-[3,4-(METHYLENEDIOXY)PHENYL]-1-BUTYLAMINEHYDROCHLORIDE

C15H17BrO3 (324.0361)


   

Boc-dap(bromoacetyl)-oh

Boc-dap(bromoacetyl)-oh

C10H17BrN2O5 (324.0321)


   

diethoxy-(4-methylsulfonylphenoxy)-sulfanylidene-λ5-phosphane

diethoxy-(4-methylsulfonylphenoxy)-sulfanylidene-λ5-phosphane

C11H17O5PS2 (324.0255)


   

N,N-Thiodiphthalimide

N,N-Thiodiphthalimide

C16H8N2O4S (324.0205)


   

trans-6-Methyl-4-ethylamino-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide

trans-6-Methyl-4-ethylamino-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide

C10H16N2O4S3 (324.0272)


   

3-[(4-CHLOROPHENYL)SULFONYL]METHYL-N-HYDROXYBENZENECARBOXIMIDAMIDE

3-[(4-CHLOROPHENYL)SULFONYL]METHYL-N-HYDROXYBENZENECARBOXIMIDAMIDE

C14H13ClN2O3S (324.0335)


   

1-(3-aminopropyl)-2-pipecoline

1-(3-aminopropyl)-2-pipecoline

C15H17BrO3 (324.0361)


   

2-(4-CHLOROSULPHONYLPHENYL)ETHYLTRIMETHOXYSILANE50 IN METHYLENE CHLORIDE

2-(4-CHLOROSULPHONYLPHENYL)ETHYLTRIMETHOXYSILANE50 IN METHYLENE CHLORIDE

C11H17ClO5SSi (324.0254)


   

2-(TRIFLUOROMETHYL)-5-[4-(TRIFLUOROMETHYL)PHENYL]-3-FUROIC ACID

2-(TRIFLUOROMETHYL)-5-[4-(TRIFLUOROMETHYL)PHENYL]-3-FUROIC ACID

C13H6F6O3 (324.0221)


   

5-Uridylic acid

5-Uridylic acid

C9H13N2O9P (324.0359)


   

1-(4-Chlorophenyl)-3-((4-methylphenyl)sulfonyl)urea

1-(4-Chlorophenyl)-3-((4-methylphenyl)sulfonyl)urea

C14H13ClN2O3S (324.0335)


   

2-(2-bromophenyl)-2,3-dihydro-1H-perimidine

2-(2-bromophenyl)-2,3-dihydro-1H-perimidine

C17H13BrN2 (324.0262)


   

Uracil arabinose-5-phosphate

Uracil arabinose-5-phosphate

C9H13N2O9P (324.0359)


   

Uracil arabinose-3-phosphate

Uracil arabinose-3-phosphate

C9H13N2O9P (324.0359)


   

L-Uridine-5-monophosphate

L-Uridine-5-monophosphate

C9H13N2O9P (324.0359)


   

a 2,4-dioxotetrahydropyrimidine D-ribonucleotide

a 2,4-dioxotetrahydropyrimidine D-ribonucleotide

C9H13N2O9P-2 (324.0359)


   

1-(3,4-Dichlorophenyl)-3-(3,5-dimethylphenyl)thiourea

1-(3,4-Dichlorophenyl)-3-(3,5-dimethylphenyl)thiourea

C15H14Cl2N2S (324.0255)


   

1-(2-Bromo-1-(trifluoromethoxy)ethyl)-4-(tert-butyl)benzene

1-(2-Bromo-1-(trifluoromethoxy)ethyl)-4-(tert-butyl)benzene

C13H16BrF3O (324.0337)


   

[4-[3-(3,5-Dihydroxyphenyl)oxiran-2-yl]phenyl] hydrogen sulate

[4-[3-(3,5-Dihydroxyphenyl)oxiran-2-yl]phenyl] hydrogen sulate

C14H12O7S (324.0304)


   

Dorzolamide

Dorzolamide

C10H16N2O4S3 (324.0272)


S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics > S01EC - Carbonic anhydrase inhibitors D004791 - Enzyme Inhibitors > D002257 - Carbonic Anhydrase Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C471 - Enzyme Inhibitor > C29577 - Carbonic Anhydrase Inhibitor

   

3-Uridylic acid

3-Uridylic acid

C9H13N2O9P (324.0359)


COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Uridine 2-phosphate

Uridine 2-phosphate

C9H13N2O9P (324.0359)


   

Pseudouridine 5-phosphate

Pseudouridine 5-phosphate

C9H13N2O9P (324.0359)


A C-nucleoside phosphate consisting of pseudouridine having a monophosphate group at the 5-position.

   

5-O-(1-carboxyvinyl)-3-phosphoshikimic acid

5-O-(1-carboxyvinyl)-3-phosphoshikimic acid

C10H13O10P (324.0246)


   

[5-(2,4-Dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[5-(2,4-Dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C9H13N2O9P (324.0359)


   

3-UMP

3-UMP

C9H13N2O9P (324.0359)


A pyrimidine ribonucleoside 3-monophosphate having uracil as the nucleobase.

   
   

Iperoxo

Iperoxo

C10H17IN2O2 (324.0335)


Iperoxo is a potent superagonist of muscarinic acetylcholine receptor (mAChR). [3H]Iperoxo can be used for direct probing activation-related conformational transitions of muscarinic receptors[1][2]. Iperoxo is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

   

(2s,3r)-6-chloro-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

(2s,3r)-6-chloro-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C15H13ClO6 (324.0401)


   
   

7-hydroxy-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione

7-hydroxy-11-(hydroxymethyl)-15-methyl-12,13-dithia-9,15-diazatetracyclo[9.2.2.0¹,⁹.0³,⁸]pentadeca-3,5,7-triene-10,14-dione

C13H12N2O4S2 (324.0238)


   

(?)-6-chloroepicatechin

NA

C15H13ClO6 (324.0401)


{"Ingredient_id": "HBIN012295","Ingredient_name": "(?)-6-chloroepicatechin","Alias": "NA","Ingredient_formula": "C15H13ClO6","Ingredient_Smile": "C1C(C(OC2=CC(=C(C(=C21)O)Cl)O)C3=CC(=C(C=C3)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "3550","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(2r,3s)-6-chloro-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

(2r,3s)-6-chloro-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C15H13ClO6 (324.0401)


   

(3r,4s,5r)-5-[(1-carboxyeth-1-en-1-yl)oxy]-4-hydroxy-3-(phosphonooxy)cyclohex-1-ene-1-carboxylic acid

(3r,4s,5r)-5-[(1-carboxyeth-1-en-1-yl)oxy]-4-hydroxy-3-(phosphonooxy)cyclohex-1-ene-1-carboxylic acid

C10H13O10P (324.0246)


   

[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxyphosphonic acid

[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxyphosphonic acid

C9H13N2O9P (324.0359)


   

(2r,3r)-6-chloro-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

(2r,3r)-6-chloro-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol

C15H13ClO6 (324.0401)


   

[(2s,3s,4s,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxyphosphonic acid

[(2s,3s,4s,5r)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxyphosphonic acid

C9H13N2O9P (324.0359)


   

3,8-dichloro-11h,12h-indolo[2,3-a]carbazole

3,8-dichloro-11h,12h-indolo[2,3-a]carbazole

C18H10Cl2N2 (324.0221)